Amazon launches cancer vaccine clinical trial in partnership with Fred Hutchinson

Amazon launches cancer vaccine clinical trial in partnership with Fred Hutchinson


Andy Jassy, chief executive officer of Amazon.Com Inc., during the GeekWire Summit in Seattle, Washington, U.S., on Tuesday, Oct. 5, 2021.

David Ryder | Bloomberg | Getty Images

Amazon is developing cancer vaccines in collaboration with the Fred Hutchinson Cancer Research Center, and it recently launched an FDA-approved clinical trial.

Amazon and Fred Hutchinson are looking to recruit 20 participants over the age of 18 for the early stage, or phase 1, trial, according to a filing on clinicaltrials.gov, a database of clinical trials run by the National Library of Medicine. The goal is to develop “personalized vaccines” that can treat breast cancer and melanoma, a form of skin cancer, the filing states.

Fred Hutchinson is listed as a sponsor of the study, while Amazon is listed as a collaborator, according to the filing. News of the partnership was first reported by Business Insider. The study was first posted last October, and it began June 9. It’s expected to be complete by Nov. 1 of 2023.

Fred Hutch and Amazon confirmed the partnership. An Amazon spokesperson said it’s being led by Fred Hutch.

“Amazon is contributing scientific and machine learning expertise to a partnership with Fred Hutch to explore the development of a personalized treatment for certain forms of cancer,” the spokesperson told CNBC in a statement. “It’s very early, but Fred Hutch recently received permission from the U.S. Food and Drug Administration to proceed with a Phase I clinical trial, and it’s unclear whether it will be successful. This will be a long, multi-year process — should it progress, we would be open to working with other organizations in health care and life sciences that might also be interested in similar efforts.”

Amazon has deepened its presence in the health-care industry in recent years. The company in 2020 launched an online pharmacy, it has ramped up its telehealth service, called Amazon Care, and it has sought to develop at-home medical diagnostics.

A secretive research and development group inside Amazon, known as Grand Challenge, initially oversaw the cancer vaccine effort, according to Business Insider, which cited people familiar with the matter. It’s now under the purview of a cancer research team reporting to Amazon’s vice president of devices, Robert Williams, Business Insider reported.

WATCH: Andy Jassy’s priority is to chart a next generation path for growth, says Madron’s McIlwain



Source

AI chipmaker Cerebras withdraws IPO
Technology

AI chipmaker Cerebras withdraws IPO

Artificial intelligence chipmaker Cerebras said on Friday that it’s withdrawing plans for an IPO, days after raising over $1 billion in a fundraising round. In a filing with the SEC, Cerebras said it does not intend to conduct a proposed offering “at this time,” but didn’t provide a reason. A spokesperson told CNBC on Friday […]

Read More
Amazon shutters 4 Fresh stores in Southern California as grocery strategy keeps shifting
Technology

Amazon shutters 4 Fresh stores in Southern California as grocery strategy keeps shifting

An employee arranges a salad dressing display at an Amazon Fresh grocery store on December 12, 2024 in Federal Way, Washington. David Ryder | Getty Images Amazon is closing four more Fresh supermarkets in Southern California as the e-commerce giant continues to focus its grocery strategy around Whole Foods and delivery. The closures will take […]

Read More
Quantum stocks Rigetti Computing and D-Wave surged double-digits this week. Here’s what’s driving the big move
Technology

Quantum stocks Rigetti Computing and D-Wave surged double-digits this week. Here’s what’s driving the big move

Inside Google’s quantum computing lab in Santa Barbara, California. CNBC Quantum computing stocks are wrapping up a big week of double-digit gains. Shares of Rigetti Computing, D-Wave Quantum and Quantum Computing have surged more than 20%. Rigetti and D-Wave Quantum have more than doubled and tripled, respectively, since the start of the year. Arqit Quantum […]

Read More